Important Update About Clinical Trials
The Veterinary Teaching Hospital at the Virginia-Maryland College of Veterinary Medicine is exercising caution and implementing measures to minimize the risk and slow the transmission of COVID-19.
Effective March 13, 2020, we will be shifting our services to provide emergency care only.
Many clinical trials appointments and rechecks will be postponed until at least April 30. As long as resources allow, the studies listed below will remain open. Since we are not yet certain when we will be able to reopen our closed studies, we will be contacting participants by email and phone as studies reopen.
We are continuing to monitor this rapidly evolving situation. We appreciate your patience and support, and apologize for any inconvenience. The health and safety of our clients, our patients, and our staff here at the Veterinary Teaching Hospital are central to our mission in providing the highest quality of care.
Need more options?
The American Veterinary Medical Association clinical research database lists hundreds of ongoing studies at sites throughout the U.S. and Canada.
Field evaluation of a rapid, mobile, novel sequencing technology for the detection of Equine Herpesvirus-1 in equine nasal secretions
Purpose: To evaluate a novel, DNA sequencing modality for diagnosing Equine herpesvirus-1 via nasal swab samples in outbreak scenarios and to further characterize the molecular epidemiology of the virus.
Purpose: To determine acute and cumulative dosing safety of the chemotherapy drug oxaliplatin in dogs with cancer, and to measure the preliminary effectiveness of the drug.
Purpose: To identify the approximate duration of time for thyroid hormone levels to return to normal following nonthyroidal illness resolution.
Purpose: To understand more about how EPM affects the immune system of horses, and discover how we might improve the diagnosis and treatment of the disease.
Identification of a genetic predisposition for Equine Protozoal Myeloencephalitis (EPM) susceptibility and associated gene dysregulation in clinically affected horses
Purpose: To determine if there is an underlying genetic predisposition for horses that develop EPM, including chronically affected horses who either fail to respond to treatment or suffer recurrent disease after ceasing treatment.